"MannKind Corporation (NASDAQ:MNKD) shares gained 5.11% to $2.48. JMP Securities upgraded shares of MannKind from a market perform rating to a market outperform rating in a research report released on August 10. The company last announced its earnings results on August 7. The company reported ($0.23) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.24) by $0.01. Analysts expect that MannKind will post $-0.97 EPS for the current fiscal year."

http://meshpress.com/top-biotech-movers-vvus-psti-affy-mnkd-dndnd/128716.html